Chemo Pharma Laboratories Ltd. has disclosed that a promoter, who became such after the open offer, sold equity shares of the company.

This mandatory disclosure by the company is to comply with insider trading regulations.

For investors, this provides crucial transparency regarding significant share transactions by key insiders, which is vital for maintaining market fairness and enabling informed investment decisions by stakeholders.

It ensures public visibility of changes in significant ownership.